Please login to the form below

Not currently logged in
Email:
Password:

Abeona

This page shows the latest Abeona news and features for those working in and with pharma, biotech and healthcare.

Abeona Therapeutics’ rare disease phase 3 trial halted due to FDA concerns

Abeona Therapeutics’ rare disease phase 3 trial halted due to FDA concerns

Abeona recently reported that EB-101 induced sustained wound healing in patients, lasting for three years or more. ... However, Abeona needs to prove the transport stability of the therapy if it wants to continue into phase 3.

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Abeona Therapeutics appoints new additions to board of directors Abeona Therapeutics appoints new additions to board of directors

    He said: “Abeona’s ambitious gene and cell therapies have the promise to bring treatments to patients for whom there are currently no treatment options available. ... I believe Abeona’s pipeline has significant potential to bring transformative

  • Abeona Therapeutics names CEO Abeona Therapeutics names CEO

    Carsten Thiel joins the biopharma from Alexion. Rare genetic disease focused biopharma Abeona Therapeutics has named its chief executive officer in the form of Carsten Thiel. ... Steven Rouhandeh, executive chairman of Abeona, said: “As CEO, Carsten

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics